Invention Grant
- Patent Title: CD37-binding molecules and immunoconjugates thereof
-
Application No.: US15233423Application Date: 2016-08-10
-
Publication No.: US10556958B2Publication Date: 2020-02-11
- Inventor: Jutta Deckert , Julianto Setiady , Peter U. Park
- Applicant: DEBIOPHARM INTERNATIONAL, S.A.
- Applicant Address: CH Lausanne
- Assignee: Debiopharm International, S.A.
- Current Assignee: Debiopharm International, S.A.
- Current Assignee Address: CH Lausanne
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395 ; A61K47/68 ; C07K16/28 ; C12N5/00
Abstract:
Methods of using CD37 agents, including, but not limited to, antibodies and immunoconjugates, that bind to CD37 to deplete B-cells (e.g., non-cancerous B-cells) and methods of treating autoimmune and inflammatory diseases are further provided.
Public/Granted literature
- US20160340438A1 CD37-BINDING MOLECULES AND IMMUNOCONJUGATES THEREOF Public/Granted day:2016-11-24
Information query
